“…In this context, stepwise methodologies have been reported in synthesizing novel pyrrolo[3,4- b ]pyridin-5-ones, for example, Devasthale and co-workers synthesized a panel of pyrrolo[3,4- b ]pyridin-5-ones, evaluating in vitro their properties as inhibitors of the dipeptidyldipentidase-4 (DPP-4) [26]. However, one efficient, versatile, and robust method to construct this polyheterocyclic core is through a one-pot cascade sequence Ugi–3CR/ aza Diels–Alder cycloaddition/ N –acylation/decarboxylation/dehydration, reported first by Zhu and co-workers [27], and further optimized by us many times [22,23,28,29,30,31,32,33,34]. Thus, for the in vitro assays against SiHa, HeLa, and CaSki cell lines, we synthesized some of our previously reported pyrrolo[3,4- b ]pyridin-5-ones 1a – j [22,32], and the new ones 1k – l , specifically prepared for the present study (Figure 1).…”